BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghaffari K, Savadkuhi ST, Honar H, Riazi K, Shafaroodi H, Moezi L, Ebrahimkhani MR, Tahmasebi MS, Dehpour AR. Obstructive cholestasis alters intestinal transit in mice: role of opioid system. Life Sci. 2004;76:397-406. [PMID: 15530502 DOI: 10.1016/j.lfs.2004.09.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Nezami BG, Talab SS, Emami H, Assa S, Rasouli MR, Asadi S, Tavangar SM, Dehpour AR. Chronic Upregulation of the Endogenous Opioid System Impairs the Skin Flap Survival in Rats. Annals of Plastic Surgery 2009;63:558-63. [DOI: 10.1097/sap.0b013e31818d458e] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ní Dhonnabháín R, Xiao Q, O'Malley D. Aberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids. Front Endocrinol (Lausanne) 2021;12:745190. [PMID: 34917022 DOI: 10.3389/fendo.2021.745190] [Reference Citation Analysis]
3 Alemi F, Poole DP, Chiu J, Schoonjans K, Cattaruzza F, Grider JR, Bunnett NW, Corvera CU. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Gastroenterology 2013;144:145-54. [PMID: 23041323 DOI: 10.1053/j.gastro.2012.09.055] [Cited by in Crossref: 159] [Cited by in F6Publishing: 155] [Article Influence: 15.9] [Reference Citation Analysis]
4 van de Wiel SM, Porteiro B, Belt SC, Vogels EW, Bolt I, Vermeulen JL, Rudi de Waart D, Verheij J, Muncan V, Oude Elferink RP, van de Graaf SF. Differential and organ-specific functions of organic solute transporter alpha and beta in experimental cholestasis. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100463] [Reference Citation Analysis]
5 Lieu T, Jayaweera G, Bunnett NW. GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation. Br J Pharmacol. 2014;171:1156-1166. [PMID: 24111923 DOI: 10.1111/bph.12426] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
6 Kiani S, Valizadeh B, Hormazdi B, Samadi H, Najafi T, Samini M, Dehpour AR. Alteration in male reproductive system in experimental cholestasis: Roles for opioids and nitric oxide overproduction. European Journal of Pharmacology 2009;615:246-51. [DOI: 10.1016/j.ejphar.2009.04.049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
7 Haj-Mirzaian A, Hamzeh N, Javadi-Paydar M, Abdollahzadeh Estakhri MR, Dehpour AR. Resistance to depression through interference of opioid and nitrergic systems in bile-duct ligated mice. Eur J Pharmacol 2013;708:38-43. [PMID: 23528353 DOI: 10.1016/j.ejphar.2013.03.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
8 Davis M. Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics. Clin Pharmacokinet 2007;46:825-50. [PMID: 17854233 DOI: 10.2165/00003088-200746100-00002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
9 Ge X, Ding C, Zhao W, Xu L, Tian H, Gong J, Zhu M, Li J, Li N. Antibiotics-induced depletion of mice microbiota induces changes in host serotonin biosynthesis and intestinal motility. J Transl Med. 2017;15:13. [PMID: 28086815 DOI: 10.1186/s12967-016-1105-4] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 15.0] [Reference Citation Analysis]
10 Peddyreddy MKR, Dkhar SA, Ramaswamy S, Naveen AT, Shewade DG. An inherent acceleratory effect of insulin on small intestinal transit and its pharmacological characterization in normal mice. World J Gastroenterol 2006; 12(16): 2593-2600 [PMID: 16688808 DOI: 10.3748/wjg.v12.i16.2593] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
11 Deroee AF, Nezami BG, Mehr SE, Hosseini R, Salmasi AH, Talab SS, Jahanzad I, Dehpour AR. Cholestasis induced nephrotoxicity: The role of endogenous opioids. Life Sciences 2010;86:488-92. [DOI: 10.1016/j.lfs.2010.02.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
12 Singh VP, Singh N, Jaggi AS. A review on renal toxicity profile of common abusive drugs. Korean J Physiol Pharmacol 2013;17:347-57. [PMID: 23946695 DOI: 10.4196/kjpp.2013.17.4.347] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
13 Mani AR, Rasool R, Montagnese S, Dehpour AR. Endogenous opioids and liver disease. Scandinavian Journal of Gastroenterology 2009;41:1-11. [DOI: 10.1080/00365520500287533] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
14 Wang Q, Gao X, Yuan Z, Wang Z, Meng Y, Cao Y, Plotnikoff NP, Griffin N, Shan F. Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs). Hum Vaccin Immunother 2014;10:1836-40. [PMID: 25424790 DOI: 10.4161/hv.28804] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
15 Moore K, Dusheiko G. Opiate abuse and viral replication in hepatitis C. Am J Pathol 2005;167:1189-91. [PMID: 16251404 DOI: 10.1016/S0002-9440(10)61207-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
16 Bodnar RJ, Klein GE. Endogenous opiates and behavior: 2004. Peptides 2005;26:2629-711. [PMID: 16039752 DOI: 10.1016/j.peptides.2005.06.010] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 3.3] [Reference Citation Analysis]